Presseportal.de - Stivargahttps://www.presseportal.de/st/Stivarga?langid=2Presseportal - Deutschlands umfassende Datenbank für Presseinformationen in Text, Bild, Ton und Video - ein Service der dpa-Tochter news aktuellde-denews aktuell GmbHhttps://www.presseportal.de/images/logos/logo-de-250.jpgPresseportal.de - Stivargahttps://www.presseportal.de/st/Stivarga?langid=2info@presseportal.de (presseportal.de)Thu, 01 Oct 2026 12:19:13 +0200Mon, 21 Sep 2026 09:59:11 +0200Stivarga6Grünenthal acquires cancer treatment Stivarga®Grünenthal Group: Aachen (ots) - - Latest step in Grünenthal’s strategy to acquire established medicines that serve clear medical needs, leverage its commercial and operational capabilities, and drive growth. - Stivarga® (regorafenib) is an established oral ...https://www.presseportal.de/pm/118252/6355662?langid=2Mon, 21 Sep 2026 09:59:11 +0200https://www.presseportal.de/pm/118252/6355662?langid=2 Grünenthal Group [Newsroom]
Aachen (ots) - - Latest step in Grünenthal’s strategy to acquire established medicines that serve clear medical needs, leverage its commercial and operational capabilities, and drive growth. - Stivarga® (regorafenib) is an established oral ... Lesen Sie hier weiter...

Original-Content von: Grünenthal Group, übermittelt durch news aktuell

]]>Gesundheit / Medizininfo@presseportal.de (presseportal.de)Grünenthal Group